Discover the SciOpen Platform and Achieve Your Research Goals with Ease.
Search articles, authors, keywords, DOl and etc.
Attention deficit hyperactivity disorder (ADHD) is one of the most prevalent psychiatric disorders in children, and ADHD patients always display circadian abnormalities. While, the ADHD drugs currently used in clinic have strong side effects, such as psychosis, allergic reactions, and heart problems. Here, we demonstrated carbon dots derived from the ascorbic acid (VCDs) could strongly rescue the hyperactive and impulsive behaviour of a zebrafish ADHD disease model caused by per1b mutation. VCDs prolonged the circadian period of zebrafish for more than half an hour. In addition, the amplitude and circadian phase were also changed. The dopamine level was specifically increased, which may be caused by stimulation of the dopaminergic neuron development in the midbrain. Notably, it was found that the serotonin level was not altered by VCDs treatments. Also, the gene transcriptome effects of VCDs were discussed in present work. Our results provided the dynamic interactions of carbon dots with circadian system and dopamine signaling pathway, which illustrates a potential application of degradable and bio-safe VCDs for the treatment of the attention deficient and hyperactive disorder through circadian intervention.
Flores-Dourojeanni, J. P.; Van Rijt, C.; Van Den Munkhof, M. H.; Boekhoudt, L.; Luijendijk, M. C. M.; Vanderschuren, L.; Adan, R. A. H. Temporally specific roles of ventral tegmental area projections to the nucleus accumbens and prefrontal cortex in attention and impulse control. J. Neurosci. 2021, 41, 4293–4304.
Mikkelsen, S. H.; Olsen, J.; Bech, B. H.; Wu, C. S.; Liew, Z.; Gissler, M.; Obel, C.; Arah, O. A. Birth asphyxia measured by the pH value of the umbilical cord blood may predict an increased risk of attention deficit hyperactivity disorder. Acta Paediatr. 2017, 106, 944–952.
Wiesner, C. D.; Molzow, I.; Prehn-Kristensen, A.; Baving, L. Sleep-dependent consolidation of rewarded behavior is diminished in children with attention deficit hyperactivity disorder and a comorbid disorder of social behavior. Front. Psychol. 2017, 8, 167.
Kendall, T.; Taylor, E.; Perez, A.; Taylor, C. Diagnosis and management of attention-deficit/hyperactivity disorder in children, young people, and adults: Summary of NICE guidance. BMJ 2008, 337, a1239.
Rosler, M.; Retz, W.; Retz-Junginger, P.; Hengesch, G.; Schneider, M.; Supprian, T.; Schwitzgebel, P.; Pinhard, K.; Dovi-Akue, N.; Wender, P. et al. Prevalence of attention deficit-/hyperactivity disorder (ADHD) and comorbid disorders in young male prison inmates. Eur. Arch. Psychiatry Clin. Neurosci. 2004, 254, 365–371.
Huang, H.; Yang, S. W.; Liu, Y.; Yang, Y. C.; Li, H.; McLeod, J. A.; Ding, G. Q.; Huang, J.; Kang, Z. H. Photocatalytic polymerization from amino acid to protein by carbon dots at room temperature. ACS Appl. Bio Mater. 2019, 2, 5144–5153.
Capuzzi, E.; Capellazzi, M.; Caldiroli, A.; Cova, F.; Auxilia, A. M.; Rubelli, P.; Tagliabue, I.; Zanvit, F. G.; Peschi, G.; Buoli, M. et al. Screening for ADHD Symptoms among Criminal Offenders: Exploring the Association with Clinical Features. Healthcare 2022, 10, 180.
Lieschke, G. J.; Currie, P. D. Animal models of human disease: Zebrafish swim into view. Nat. Rev. Genet. 2007, 8, 353–367.
Huang, J.; Zhong, Z. M.; Wang, M. Y.; Chen, X. F.; Tan, Y. C.; Zhang, S. Q.; He, W.; He, X.; Huang, G. D.; Lu, H. P. et al. Circadian modulation of dopamine levels and dopaminergic neuron development contributes to attention deficiency and hyperactive behavior. J. Neurosci. 2015, 35, 2572–2587.
Whalley, K. A zebrafish model of ADHD. Nat. Rev. Neurosci. 2015, 16, 188.
Xue, X.; Yang, J. Y.; He, Y.; Wang, L. R.; Liu, P.; Yu, L. S.; Bi, G. H.; Zhu, M. M.; Liu, Y. Y.; Xiang, R. W. et al. Aggregated single-walled carbon nanotubes attenuate the behavioural and neurochemical effects of methamphetamine in mice. Nat. Nanotechnol. 2016, 11, 613–620.
Kim, D.; Yoo, J. M.; Hwang, H.; Lee, J.; Lee, S. H.; Yun, S. P.; Park, M. J.; Lee, M.; Choi, S.; Kwon, S. H.; Lee, S.; Kwon, S. H. et al. Graphene quantum dots prevent α-synucleinopathy in Parkinson's disease. Nat. Nanotechnol. 2018, 13, 812–818.
Black, N.; Stockings, E.; Campbell, G.; Tran, L. T.; Zagic, D.; Hall, W. D.; Farrell, M.; Degenhardt, L. Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: A systematic review and meta-analysis. Lancet Psychiatry 2019, 6, 995–1010.
Hua, Y. F.; Wang, C.; Huang, J.; Wang, K. J. A simple and efficient method for CRISPR/Cas9-induced mutant screening. J. Genet. Genom. 2017, 44, 207–213.
Liu, A. N.; Xu, Y. W.; Yan, Q.; Tong, L. The prevalence of attention deficit/hyperactivity disorder among Chinese children and adolescents. Sci. Rep. 2018, 8, 11169.
Garner, I.; Vichare, R.; Paulson, R.; Appavu, R.; Panguluri, S. K.; Tzekov, R.; Sahiner, N.; Ayyala, R.; Biswal, M. R. Carbon dots fabrication: Ocular imaging and therapeutic potential. Front. Bioeng. Biotechnol. 2020, 8, 573407.
Posner, J.; Polanczyk, G. V.; Sonuga-Barke, E. Attention-deficit hyperactivity disorder. Lancet 2020, 395, 450–462.
Li, H.; Huang, J.; Song, Y. X.; Zhang, M. L.; Wang, H. B.; Lu, F.; Huang, H.; Liu, Y.; Dai, X.; Gu, Z. L. et al. Degradable carbon dots with broad-spectrum antibacterial activity. ACS Appl. Mater. Interfaces 2018, 10, 26936–26946.
Li, H.; Huang, J.; Liu, Y.; Lu, F.; Zhong, J.; Wang, Y.; Li, S. M.; Lifshitz, Y.; Lee, S. T.; Kang, Z. H. Enhanced RuBisCO activity and promoted dicotyledons growth with degradable carbon dots. Nano Res. 2019, 12, 1585–1593.
VanGuilder, H. D.; Vrana, K. E.; Freeman, W. M. Twenty-five years of quantitative PCR for gene expression analysis. BioTechniques 2008, 44, 619–626.
Grabherr, M. G.; Haas, B. J.; Yassour, M.; Levin, J. Z.; Thompson, D. A.; Amit, I.; Adiconis, X.; Fan, L.; Raychowdhury, R.; Zeng, Q. D. et al. Full-length transcriptome assembly from RNA-Seq data without a reference genome. Nat. Biotechnol. 2011, 29, 644–652.
Yu, Y.; Sun, H. Y.; Gilmore, K.; Hou, T. J.; Wang, S. D.; Li, Y. Y. Aggregated single-walled carbon nanotubes absorb and deform dopamine-related proteins based on molecular dynamics simulations. ACS Appl. Mater. Interfaces 2017, 9, 32452–32462.
Bolyard, K. J.; Rowland, W. J. Context-dependent response to red coloration in stickleback. Anim. Behav. 1996, 52, 923–927.
Burns, G. L.; Walsh, J. A.; Servera, M.; Lorenzo-Seva, U.; Cardo, E.; Rodriguez-Fornells, A. Construct validity of ADHD/ODD rating scales: Recommendations for the evaluation of forthcoming DSM-V ADHD/ODD scales. J. Abnorm. Child Psychol. 2013, 41, 15–26.
Gong, R.; Ding, C.; Hu, J.; Lu, Y.; Liu, F.; Mann, E.; Xu, F. Q.; Cohen, M. B.; Luo, M. M. Role for the membrane receptor guanylyl cyclase-C in attention deficiency and hyperactive behavior. Science 2011, 333, 1642–1646.
Hanswijk, S. I.; Spoelder, M.; Shan, L.; Verheij, M. M. M.; Muilwijk, O. G.; Li, W. Z.; Liu, C. Q.; Kolk, S. M.; Homberg, J. R. Gestational factors throughout fetal neurodevelopment: The serotonin link. Int. J. Mol. Sci. 2020, 21, 5850.
Bornstein, R. A.; Baker, G. B.; Carroll, A.; King, G.; Wong, J. T. F.; Douglass, A. B. Plasma amino acids in attention deficit disorder. Psychiatry Res. 1990, 33, 301–306.
Ryu, S.; Mahler, J.; Acampora, D.; Holzschuh, J.; Erhardt, S.; Omodei, D.; Simeone, A.; Driever, W. Orthopedia homeodomain protein is essential for diencephalic dopaminergic neuron development. Curr. Biol. 2007, 17, 873–880.
Lange, M.; Norton, W.; Coolen, M.; Chaminade, M.; Merker, S.; Proft, F.; Schmitt, A.; Vernier, P.; Lesch, K. P.; Bally-Cuif, L. The ADHD-susceptibility gene lphn3.1 modulates dopaminergic neuron formation and locomotor activity during zebrafish development. Mol. Psychiatry 2012, 17, 946–954.
Arcos-Burgos, M.; Jain, M.; Acosta, M. T.; Shively, S.; Stanescu, H.; Wallis, D.; Domené, S.; Vélez, J. I.; Karkera, J. D.; Balog, J. et al. A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol. Psychiatry 2010, 15, 1053–1066.
Tay, T. L.; Ronneberger, O.; Ryu, S.; Nitschke, R.; Driever, W. Comprehensive catecholaminergic projectome analysis reveals single-neuron integration of zebrafish ascending and descending dopaminergic systems. Nat. Commun. 2011, 2, 171.